Foghorn Therapeutics Inc. (FHTX) Earnings
|
Expand Research on FHTX
| Next EPS Date | 11/10/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +6.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +7.7% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/10/26  |
Q326 | N/A | -$0.24 | N/A | N/A | $7.1M | N/A | N/A | N/A | ||
| 8/6/26 |
Q226 | -$0.10 | -$0.25 | +$0.15 | $16.1M | $7.59M | N/A |  | | Details | |
| 5/7/26 |
Q126 | -$0.29 | -$0.28 | -$0.01 | $3.26M | $9.35M | N/A | | | Details | |
| 3/11/26 |
Q425 | N/A | -$0.25 | N/A | N/A | $9.49M | N/A | N/A | N/A | ||
| 3/10/26 |
Q425 | N/A | -$0.25 | N/A | N/A | $9.49M | N/A | N/A | N/A | ||
| 3/9/26 |
Q425 | N/A | -$0.25 | N/A | N/A | $9.49M | N/A | N/A | N/A | ||
| 3/6/26 |
Q425 | N/A | -$0.25 | N/A | N/A | $9.49M | N/A | N/A | N/A | ||
| 3/5/26 |
Q425 | N/A | -$0.25 | N/A | N/A | $9.49M | N/A | N/A | N/A |
